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Intravenous devices are a leading cause of nosocomial infections (NIs) that can be reduced by specific prevention strategies and improved guidelines for their use. However, the impact of a combination of these strategies on vascular access infection (VAI) rates in ICUs remains to be determined. Investigators from the medical ICU and the infection control program at the University of Geneva Hospitals, Switzerland, implemented a multipleapproach prevention program to decrease VAI. Between October 1995 and November 1997, a total of 3,154 critically ill patients admitted to the medical ICU was included in a cohort study with longitudinal evaluation of an overall catheter-care policy and based on an educational campaign for VAI and device utilization and care.
The intervention strategy was implemented in March 1997, and its impact was measured during an 8-month intervention period. An educational campaign consisting of 30-minute slide shows was initiated and included detailed information on clinical pathways for VAI, and device maintenance and utilization, based on previously identified risk factors. The guidelines covered the following: preparation of the material to avoid any interruption during insertion; skin preparation and antisepsis; maximal barrier precautions; and subclavian or wrist vein as standard insertion sites. Hand hygiene was strongly emphasized before and after insertion, replacement, or the manipulation of any vascular device. Central lines were not routinely replaced, but were changed over a guidewire in case of clinical sepsis without a documented source of infection. Prompt removal of any device not intended for use was strongly recommended.
A total of 613 infections occurred in 353 patients (19.4 infections/100 admissions). Following the intervention, the incidence-density of exit-site catheter infection decreased from 9.2 to 3.3 episodes per 1,000 patient-days, and bloodstream infections 03SIs) decreased from 11.3 to 3.8 per 1,000 patient-days due to reduced rates of both microbiologically documented infections and clinical sepsis. Overall, the incidence of all ICU-acquired NIs was reduced by 35%, from 52.4 to 34.0 episodes per 1,000 patient-days.
The results demonstrate the impact of a multiple-approach intervention strategy on bloodstream and catheter-related infection rates, as well as on the overall incidence of ICU-acquired NI. Although infection rates before the intervention (ie, 6.6 episodes of microbiologically documented BSIs/1,000 central venous catheter-days) were within the accepted limits, the study confirmed that a large proportion of NI related to extrinsic factors is still preventable and that intervention strategy targeted at vascular access can have a significant impact on the overall incidence of NIs.
The investigators believe that the multidimensional intervention was successful in decreasing infection rates because it targeted multiple behavioral and catheter-care related factors. They note that the strategy was just as successful in reducing VAI rates as the use of newly introduced antibiotic-/antisepticcoated catheters, which have the potential of being associated with acquisition of antibiotic resistance and allergic or toxic reaction. They estimated that this program and infections prevented, at a minimum, equal the annual salary of three full-time infection control practitioners.
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